A Study Investigating the Excretion Balance, Pharmacokinetics and Metabolism of a Single Oral Dose of [14C]-Labeled Risdiplam (RO7034067) in Healthy Male Participants
Clinical trial NCT03036501 · COMPLETED
Trial details
- NCT number
- NCT03036501
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-03
- Primary completion
- 2017-02-28
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.